Literature DB >> 22346525

Primary pulmonary hypertension and human immunodeficiency virus infection.

J Conly1, R Hilsden, H Deneer, I Etches, T Moyana.   

Abstract

This report details the case of a 42-year-old homosexual Caucasian male with infection due to human immunodeficiency virus type 1 (HIV-1) who presented with a four-month history of progressive dyspnea and was found to have clinical and hemodynamic evidence of severe pulmonary hypertension. He had had no opportunistic infections, and had a T helper lymphocyte count of 200×10(6)/L. Extensive clinical laboratory and radiological evaluations revealed no underlying cause. Microscopic examination of postmortem lung tissue revealed findings consistent with grade V pulmonary hypertension. Electron microscopic analysis and polyermase chain reaction detection of HIV-DNA from dissected pulmonary arterioles failed to provide any supportive evidence to suggest productive infection of the pulmonary arteriolar endothelial cells by HIV-1. Although HIV-1 likely plays a role in the pathogenesis of primary pulmonary hypertension, evidence for direct infection of pulmonary vessel endothelium was lacking in this case. The pathogenesis of primary pulmonary hypertension associated with HIV remains obscure.

Entities:  

Keywords:  AIDS; Pulmonary hypertension

Year:  1997        PMID: 22346525      PMCID: PMC3250892          DOI: 10.1155/1997/764297

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  20 in total

1.  Primary pulmonary hypertension and HIV infection.

Authors:  E J Aarons; F J Nye
Journal:  AIDS       Date:  1991-10       Impact factor: 4.177

2.  Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome.

Authors:  R B Himelman; M Dohrmann; P Goodman; N B Schiller; N F Starksen; M Warnock; M D Cheitlin
Journal:  Am J Cardiol       Date:  1989-12-01       Impact factor: 2.778

3.  Immune function of vascular endothelial cells is impaired by HIV.

Authors:  J M Teitel; A Shore; S E Read; A Schiavone
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

4.  Pulmonary hypertension and HIV infection.

Authors:  B Legoux; A M Piette; P F Bouchet; J F Landau; P Gepner; A M Chapman
Journal:  Am J Med       Date:  1990-07       Impact factor: 4.965

5.  Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome.

Authors:  D W Anderson; R Virmani; J M Reilly; T O'Leary; R E Cunnion; M Robinowitz; A M Macher; U Punja; S T Villaflor; J E Parrillo
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

6.  Endothelial cells: target for the HIV1 virus?

Authors:  L Drouet; M L Scrobohaci; M Janier; B Baudin
Journal:  Nouv Rev Fr Hematol       Date:  1990

7.  The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.

Authors:  J Vogel; S H Hinrichs; R K Reynolds; P A Luciw; G Jay
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

8.  Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

Authors:  S Nakamura; S Z Salahuddin; P Biberfeld; B Ensoli; P D Markham; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

9.  Primary pulmonary hypertension in HIV infection.

Authors:  R Speich; R Jenni; M Opravil; M Pfab; E W Russi
Journal:  Chest       Date:  1991-11       Impact factor: 9.410

10.  Primary pulmonary hypertension in patients with classic hemophilia.

Authors:  G H Goldsmith; R G Baily; D B Brettler; W R Davidson; J O Ballard; T E Driscol; J M Greenberg; C K Kasper; P H Levine; O D Ratnoff
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

View more
  1 in total

Review 1.  Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the Literature.

Authors:  Arnaud Grégoire L'Huillier; Klara Maria Posfay-Barbe; Hiba Pictet; Maurice Beghetti
Journal:  Front Pediatr       Date:  2015-04-07       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.